These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 4651903

  • 1. [Moniliases as a complication of corticosteroid therapy].
    Samarina AG, Furman GA.
    Vestn Dermatol Venerol; 1972 Sep; 46(9):43-6. PubMed ID: 4651903
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Some dangers of corticosteroid treatment in dermatology].
    Goerz G.
    Z Haut Geschlechtskr; 1968 May 15; 43(10):409-14. PubMed ID: 4236885
    [No Abstract] [Full Text] [Related]

  • 4. [Controlled experimentation on the therapeutic effect of 2 topical anti-inflammatory steroids].
    Carbone G, Massone L.
    Arch Ital Dermatol Venereol Sessuol; 1970 May 15; 36(3):207-14. PubMed ID: 4919648
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Corticosteroid therapy in dermatology].
    Tronnier H.
    Z Allgemeinmed; 1969 Jul 31; 45(21):985-94. PubMed ID: 5354164
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of glucocorticoid therapy on the function of the endocrine glands in patients with autoimmune skin diseases].
    Grando SA, Glukhen'kiĭ BT, Kutsenko NS, Lastovetskaia GI, Boĭko IuIa.
    Vrach Delo; 1988 Aug 31; (8):86-8. PubMed ID: 3206893
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G, Hoon TS, Leok GC.
    Arch Dermatol; 2001 Apr 31; 137(4):477-81. PubMed ID: 11295929
    [Abstract] [Full Text] [Related]

  • 11. [Our experience with Topsyne APG, a new topical corticosteroid].
    Témime P, Privat Y, Marchand JP, Llucia P.
    Therapeutique; 1971 Dec 31; 47(10):857-9. PubMed ID: 5145548
    [No Abstract] [Full Text] [Related]

  • 12. [Adverse effects of local corticosteroid therapy].
    Friis B, Weismann K.
    Ugeskr Laeger; 1972 Jul 31; 134(31):1608-12. PubMed ID: 4262229
    [No Abstract] [Full Text] [Related]

  • 13. [Experiences with antimetabolic therapy in dermatology].
    Dethlefs B, Tronnier H.
    Dermatol Monatsschr; 1973 Jan 31; 159(1):34-44. PubMed ID: 4712538
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A new topical steroid.
    Dexter DD.
    West Med Med J West; 1966 Aug 31; 7(8):222-4. PubMed ID: 6013418
    [No Abstract] [Full Text] [Related]

  • 16. [Use of locacorten in dermatologic practice].
    Agzibegova VA, Alaverdova VM, Annenkova AV, Belen'kaia SS, Vladimirova LI, Tiurikova MI.
    Vestn Dermatol Venerol; 1968 Nov 31; 42(11):83-4. PubMed ID: 5747701
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Locacorten in the treatment of skin diseases].
    Savel'eva TL, Lenartovich VA, Novozhilova TP, Kharenko VI, Pavlova VI.
    Vestn Dermatol Venerol; 1968 Mar 31; 42(3):69-72. PubMed ID: 5741251
    [No Abstract] [Full Text] [Related]

  • 19. [Cutaneous manifestations in long-term general corticotherapy. Study of 100 cases].
    Colomb D.
    Presse Med (1893); 1971 May 01; 79(22):1011-2. PubMed ID: 5314259
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of some skin diseases with sinalar ointment].
    Kolokolova NV, Frolova ON.
    Sov Med; 1966 Dec 01; 29(12):123-5. PubMed ID: 6003492
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.